JP2013515752A5 - - Google Patents

Download PDF

Info

Publication number
JP2013515752A5
JP2013515752A5 JP2012546361A JP2012546361A JP2013515752A5 JP 2013515752 A5 JP2013515752 A5 JP 2013515752A5 JP 2012546361 A JP2012546361 A JP 2012546361A JP 2012546361 A JP2012546361 A JP 2012546361A JP 2013515752 A5 JP2013515752 A5 JP 2013515752A5
Authority
JP
Japan
Prior art keywords
carboline
cyclo
pharmaceutical composition
och
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012546361A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013515752A (ja
JP5627705B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DE2010/001530 external-priority patent/WO2011079841A1/de
Publication of JP2013515752A publication Critical patent/JP2013515752A/ja
Publication of JP2013515752A5 publication Critical patent/JP2013515752A5/ja
Application granted granted Critical
Publication of JP5627705B2 publication Critical patent/JP5627705B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012546361A 2009-12-28 2010-12-28 聴力損傷および目まいの治療用のβ−カルボリン Active JP5627705B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE102009060811.7 2009-12-28
DE102009060811 2009-12-28
US28239510P 2010-02-02 2010-02-02
US61/282,395 2010-02-02
PCT/DE2010/001530 WO2011079841A1 (de) 2009-12-28 2010-12-28 Beta-carboline zur behandlung von hörschäden und schwindel

Publications (3)

Publication Number Publication Date
JP2013515752A JP2013515752A (ja) 2013-05-09
JP2013515752A5 true JP2013515752A5 (https=) 2013-10-24
JP5627705B2 JP5627705B2 (ja) 2014-11-19

Family

ID=44246908

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012546361A Active JP5627705B2 (ja) 2009-12-28 2010-12-28 聴力損傷および目まいの治療用のβ−カルボリン

Country Status (17)

Country Link
US (1) US9107914B2 (https=)
EP (1) EP2519238B1 (https=)
JP (1) JP5627705B2 (https=)
KR (1) KR20120098855A (https=)
CN (1) CN102844029A (https=)
AU (1) AU2010338669A1 (https=)
BR (1) BR112012015967B1 (https=)
CA (1) CA2785233C (https=)
DE (1) DE112010005017A5 (https=)
IL (1) IL220661A (https=)
IN (1) IN2012DN05066A (https=)
MX (1) MX2012007678A (https=)
NZ (1) NZ600478A (https=)
RU (1) RU2012132429A (https=)
SG (1) SG181599A1 (https=)
WO (1) WO2011079841A1 (https=)
ZA (1) ZA201204476B (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105120863B (zh) * 2013-03-14 2021-06-04 奥斯特克有限公司 促进骨生长的烷基胺骆驼蓬碱衍生物
LT2970890T (lt) 2013-03-14 2020-07-10 The Brigham And Women`S Hospital, Inc. Kompozicijos ir būdai, skirti epitelinių kamieninių ląstelių padauginimui ir kultivavimui
EP2853533A1 (de) 2013-09-29 2015-04-01 Audiocure Pharma GmbH 6-Fluor-9-methyl-ß-carbolin
WO2016037016A1 (en) 2014-09-03 2016-03-10 The Brigham And Women's Hospital, Inc. Compositions, systems, and methods for generating inner ear hair cells for treatment of hearing loss
CN108779437A (zh) 2016-01-08 2018-11-09 麻省理工学院 分化的肠内分泌细胞和胰岛素产生细胞的制备
US10213511B2 (en) 2016-03-02 2019-02-26 Frequency Therapeutics, Inc. Thermoreversible compositions for administration of therapeutic agents
US11260130B2 (en) 2016-03-02 2022-03-01 Frequency Therapeutics, Inc. Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using a GSK3 inhibitor: IV
US10201540B2 (en) 2016-03-02 2019-02-12 Frequency Therapeutics, Inc. Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using GSK3 inhibitors: I
EP3321264A1 (en) * 2016-11-14 2018-05-16 Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft Selective inhibitors of genotoxic stress-induced ikk/nf-kb pathways
US11066419B2 (en) 2016-12-30 2021-07-20 Frequency Therapeutics, Inc. 1H-pyrrole-2,5-dione compounds and methods of using same
CA3109104A1 (en) 2018-08-14 2020-02-20 Osteoqc Inc. Fluoro .beta.-carboline compounds
CA3108714A1 (en) 2018-08-14 2020-02-20 Osteoqc Inc. Pyrrolo - dipyridine compounds
CN113195707A (zh) 2018-08-17 2021-07-30 频率治疗公司 用于通过上调jag-1来生成毛细胞的组合物和方法
US11617745B2 (en) 2018-08-17 2023-04-04 Frequency Therapeutics, Inc. Compositions and methods for generating hair cells by downregulating FOXO
AU2019339352B2 (en) 2018-09-12 2025-05-22 Hough Ear Institute Methods for treating hearing loss incident to cochlear implant surgery
EP3772515A1 (en) 2019-08-09 2021-02-10 Audiocure Pharma GmbH Stable polymorphic form of 6-fluoro-9-methyl-9h-ss-carboline and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3240514A1 (de) 1982-10-29 1984-05-03 Schering AG, 1000 Berlin und 4709 Bergkamen Ss-carboline, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
CA2140722A1 (en) 1994-01-24 1995-07-25 Joseph A. Jakubowski Beta-carboline thromboxane synthase inhibitors
HUP0302962A2 (hu) * 1998-06-12 2003-12-29 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Béta-karbolinszármazékok, ezeket a vegyületeket tartalmazó gyógyászati készítmények és a vegyületek alkalmazása
US20040038970A1 (en) * 1998-06-12 2004-02-26 Societe De Conseils De Recherches Etd' Application Scientifiques, S.A.S. A Paris, France Corp. Beta-carboline compounds
US20050137220A1 (en) * 2003-07-23 2005-06-23 Pharmacia Corporation Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors
DE102007009264A1 (de) * 2007-02-26 2008-08-28 Ellneuroxx Ltd. 9-Alkyl-ß-Carboline zur Behandlung von neurodegenerativen Erkrankungen

Similar Documents

Publication Publication Date Title
JP2013515752A5 (https=)
RU2012132429A (ru) Бета-карболины для лечения нарушения слуха и головокружения
WO2012125926A3 (en) Tetracyclic xanthene derivatives and methods of use thereof for the treatment of viral diseases
WO2012142093A3 (en) 2'-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
JP2015523546A5 (https=)
JP2015510941A5 (https=)
JP2018035197A5 (https=)
JP2011201907A5 (https=)
WO2012018534A3 (en) Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases
JP2013510120A5 (https=)
JP2011529070A5 (https=)
JP2017523152A5 (https=)
JP2013541514A5 (https=)
JP2009542815A5 (https=)
RU2012107109A (ru) Бициклическое соединение и его применение для медицинских целей
JP2011507896A5 (https=)
JP2006528685A5 (https=)
JP2005527605A5 (https=)
JP2019535723A5 (https=)
JP2015051983A5 (https=)
JP2015519368A5 (https=)
RU2017118405A (ru) Новое лечение роговицы с применением ламинина
JP2012144537A5 (https=)
AU2017261303A1 (en) Ophthalmic compositions
JP2015502973A5 (https=)